Celesteion™ PUREViSION Edition PET/CT
86-year-old male, lymphoma staging. 12.5mCi F-18 FDG was injected intravenously. CT and PET images were acquired on a Canon Medical Systems Celesteion™ PUREViSION Edition PET/CT scanner after a 90 minute uptake period.
Scan shows abnormal cervical, thoracic, axillary, abdominal, pelvic, and inguinal adenopathy. Extensive lymphomatous uptake.
PET | |
Region Covered | Skull Base to Mid-Thigh |
Injected Dose | 12.5 mCi of 18F-FDG |
Acquisition Time | 2.5 min/bed |
Number of Beds | 8 |
Uptake Time | 90 min |
Glucose Level | 81 mg/dl |
Reconstruction | TOF |
CT | |
Scan Mode | Helical |
Collimation | 1.0 mm x 16 |
kVp | 120 |
mAs | SURE Exposure |
Rotation Time | 0.5 s |
Scan Range | 980 mm |
Dose Reduction | AIDR3D |
CTDIvol | 5.8 mGy |
DLP | 510.4 mGy.cm |
Celesteion™ PUREViSION Edition PET/CT
68-year-old female with BMI of 38.3. Biopsy proven right-sided breast cancer. Referred for initial staging.
16.6mCi F-18 FDG was injected intravenously. Low dose CT and PET images were acquired on a Canon Medical Systems Celesteion™ PUREViSION Edition PET/CT scanner after a 60 minute uptake period.
The hypermetabolic density extending from the right breast areola represents the patient's primary breast malignancy. Metastatic disease is seen in the upper outer quadrant of the right breast.
PET | |
Region Covered | Skull Base to Mid-Thigh |
Injected Dose | 16.6 mCi of 18F-FDG |
Acquisition Time | 3.0 min/bed |
Number of Beds | 8 |
Uptake Time | 60 min |
Glucose Level | 180 mg/dl |
Reconstruction | TOF |
CT | |
Scan Mode | Helical |
Collimation | 1.0 mm x 16 |
kVp | 120 |
mAs | SURE Exposure |
Rotation Time | 0.5 s |
Scan Range | 816 mm |
Dose Reduction | AIDR3D |
CTDIvol | 14.70 mGy |
DLP | 1200.50 mGy.cm |
© CANON MEDICAL SYSTEMS DO BRASIL LTDA.
© CANON MEDICAL SYSTEMS DO BRASIL LTDA.